References

  1. WHO. The Global MDR-TB and XDR-TB Response Plan 2007-2008. Geneva; 2007. Google Scholar

  2. Sharma SK, Mohan A. Multidrug-resistant tuberculosis. Indian J Med Res. 2004 Oct;120(4):354-76. PubMed | Google Scholar

  3. Federal Ministry of Health of Ethiopia (FMOH): Tuberculosis, leprosy and TB/HIV prevention and control program (manual). Addis Ababa: MOH; 2008. Google Scholar

  4. WHO. WHO country Cooperation Strategy: WHO, Ethiopia; 2009. Google Scholar

  5. WHO. Drug Resistance Tuberculosis Now at Record Levels; 2010. Google Scholar

  6. Federal Ministry of Health (FMOH): Guideline for Program and Clinical Management of Drug Resistant Tuberculosis. Addis Ababa: FMOH; 2009. Google Scholar

  7. Espinal MA, Kim SJ, Suarez PG, Kam KM, Khomenko AG, Migliori GB. Standard short-course chemotherapy for drug-resistant tuberculosis: Treatment Outcomes in 6 Countries. Journal of the American Medical Association. 2000; 283(19):2537-2545. PubMed | Google Scholar

  8. Ireneau S, Fitzpatrick C, Dennis F, Bashir S, Peter A. Multidrug resistant tuberculosis Somalia. Emerging Infectious Diseases. 2013 Mar;19(3):478-80. PubMed | Google Scholar

  9. Skrahina A, Hurevich H, Zalutskaya A, Sahalchyk E, Astrauko A, Hoffner S et al. Multidrug-resistant tuberculosis in Belarus: the size of the problem and associated risk factors. Bulletin of the World Health Organization. 2010; 91(1):36-45. PubMed | Google Scholar

  10. WHO. Guidelines for the Programmatic Management of Drug-Resistant Tuberculosis. Geneva; 2006. Google Scholar

  11. Tadesse F. Risk factors for multidrug-resistant tuberculosis in Addis Ababa Ethiopia. Universal Journal of Public Health. 2015;3(2):65-70. PubMed | Google Scholar

  12. Burki T. Tuberculosis-resistance, funding, and drugs. Lancet Infect Dis. 2010 May;10(5):297-8. PubMed | Google Scholar

  13. Yang X, Li Y, Wen X, Wu X, Li X. Risk factors for drug resistance in pulmonary tuberculosis in patients. J Evid Based Med. 2010 Aug;3(3):162-7. PubMed | Google Scholar

  14. Hirpa S, Medhin G, Girma B, Melese M, Mekonen A. Determinants of multidrug-resistant tuberculosis in patients who underwent first-line treatment in Addis Ababa: a case control study. BMC Public Health. 2013;13:782. PubMed | Google Scholar

  15. European Centre for Disease Prevention and Control: Rapid Risk Assessment: Healthcare system factors influencing treatment results of MDR TB patient. Stockholm: ECDC; 2014. Google Scholar

  16. Suárez García I, Rodríguez Blanco A, Vidal Pérez JL, García Viejo MA, Jaras Hernández MJ. Risk factors for multidrug-resistant tuberculosis in a tuberculosis unit in Madrid, Spain. Eur J Clin Microbiol Infect Dis. 2009, 28(4):325-330. PubMed | Google Scholar

  17. Flora MS, Amin MN, Karim MR, Afros S, Islam S, Alam A. Risk factors of multi drug resistant tuberculosis in bangladeshi population: a case control study. Bangladesh Medical Research Council Bulletin. 2013 Apr;39(1):34-41. PubMed | Google Scholar

  18. Duarte R, Santos A, Mota M, Carvalho A, Marques A, Barros H. Involving community partners in the management of tuberculosis among drug users. Public Health. 2011 Jan;125(1):60-2. PubMed | Google Scholar

  19. Abate D, Taye B, Abisino M, Bidglign S. Epidemiology of anti-Tuberculosis drug resistance patterns and trends in tuberculosis referral hospital in Addis Ababa. Ethiopia BMC Res notes. 2012;5:462. PubMed | Google Scholar

  20. Berhan A, Berhan Y, Yizengaw D. A meta -analysis of drug resistant tuberculosis in Sub-Saharan Africa: how strongly associated with previous treatment and HIV co-infection?. Ethiop J Health Sci. 2013;23(3):271-282. PubMed | Google Scholar

  21. Grant A, Gothard P, Thwaites G. Managing drug resistant tuberculosis. BMJ. 2008;28:338. PubMed | Google Scholar

  22. Moonan P, Quituga T, Pogoda J, Woo G, Drewyer G, Sahbazian B, Denise Dunbar, Kenneth Jost C, Charles Wallace, Stephen Weis E. Does Directly Observed Therapy (DOT) Reduce Drug Resistant Tuberculosis?. BMC Public Health. 2011;11:19. PubMed | Google Scholar

  23. Cohen T, Murray M, Abubakar I. Multiple introductions of multidrug-resistant tuberculosis into households, Lima, Peru. Emerging Infectious Diseases. 2011;17(6):969-975. PubMed | Google Scholar

  24. Kanaya AM, Glidden DV, Chambers HF. Identifying pulmonary tuberculosis in patients with negative sputum smear results. Chest. 2001 Aug;120(2):349-55. PubMed | Google Scholar

  25. WHO. Treatment of Tuberculosis: Guidelines for National Programmes. Geneva: WHO; 2010. Google Scholar

  26. Ormerod LP. Multidrug-resistant tuberculosis (MDR-TB): epidemiology, prevention and treatment. Br Med Bull. 2005 Jun 14;73-74:17-24. PubMed | Google Scholar

  27. Fischl MA, Uttamchandani RB, Daikos GL. An outbreak of tuberculosis caused by multiple-drug-resistant tubercle bacilli among patients with HIV infection. Ann Intern Med. 1992 Aug 1;117(3):177-83. PubMed | Google Scholar

  28. Akksilp S. Multidrug-resistant TB and HIV in Thailand: overlapping, but not independently associated, risk factors. Southeast Asian J Trop Med Public Health. 2009; 40:1000-1014. PubMed | Google Scholar

  29. Weyer K, Brand J, Lancaster J, levin J, van der Walt M. Determinants of multidrug-resistant tuberculosis in South Africa: results from a national survey 2007. S Afr Med J. 2007 Nov;97(11 Pt 3):1120-8. PubMed | Google Scholar

  30. WHO. Multidrug and Extensively Drug-Resistant TB (M/XDR-TB). Geneva: WHO; 2010. Google Scholar

  31. Gomes M, Correia A, Mendonça D, Duarte R. Risk factors for drug resistant tuberculosis. Journal of Tuberculosis Research. 2014;2:111-118. Google Scholar

  32. Rehm J, Samokhvalov AV, Neuman MG, Room R, Parry C, K L, Patra J, Poznyak V, Popova S. The association between alcohol use, alcohol use disorders and tuberculosis (TB): a systematic review. BMC Public Health. 2009; 9:450. PubMed | Google Scholar

  33. Kidenya BR, Webster LE, Behan S, Kabangila R, Peck RN, Mshana SE, Ocheretina O, Fitzgerald DW. Epidemiology and genetic diversity of multidrug-resistant tuberculosis in East Africa. Tuberculosis (Edinb). 2013;94(1):1-7. PubMed | Google Scholar

  34. Arinaminpathy N, Dye C. Health in financial crises: economic recession and tuberculosis in Central and Eastern Europe. J R Soc Interface. 2010 Nov 6;7(52):1559-69. PubMed | Google Scholar

  35. Lee JH, Chang JH. Drug-resistant tuberculosis in a tertiary referral teaching hospital of Korea. Korean J Intern Med. 2001;16(3):173-117. PubMed | Google Scholar

  36. Dubrovina I, Miskinis K, Lyepshina S, Yann Y, Hoffmann H, Zaleskis R, Nunn P, Zignol M. Drug-resistant tuberculosis and HIV in Ukraine: a threatening convergence of two epidemics?. Int J Tuberc Lung Dis. 2008 Jul;12(7):756-62. PubMed | Google Scholar

  37. Kimerling ME, Slavuckij A, Chavers S, Peremtin GG, Tonkel T, Sirotkina O, Golubchikova V, Baddeley A. The risk of MDR-TB and poly-resistant tuberculosis among the civilian population of Tomsk city, Siberia, 1999. Int J Tuberc Lung Dis. 2003 Sep;7(9):866-72. PubMed | Google Scholar